Skip to main content

Eldorado Gold(ELD-T)
TSX

Today's Change
Real-Time Last Update

Biorasi Welcomes Dermatologist Dr. Lawrence Green to Scientific Advisory Board

Business Wire - Tue Feb 9, 2021

Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of dermatologist Lawrence Green, MD, FAAD to the position of Scientific Advisory Board (SAB) member. In this role, Dr. Green will provide leadership and clinical expertise for dermatology clinical trials and related areas at Biorasi.

“Dr. Green is a distinguished leader in dermatology and the treatment of skin disorders,” said Dipali Patel, MD, Director of Medical Monitoring and Safety at Biorasi. “His experience will add a new perspective to our SAB team for 2021 and beyond.”

Dr. Green is one of four SAB members that will be joining Biorasi in 2021. This esteemed group of clinicians and researchers will include experts in the fields of dermatology, nephrology, neurology, and oncology, working together with Biorasi’s Board of Directors and company leadership.

Dr. Green is the founder of the Aesthetic and Dermatology Center in Rockville, Maryland, and Clinical Professor of Dermatology at George Washington University School of Medicine. He is a board-certified dermatologist, accomplished clinician-researcher, and an author or coauthor on over 50 medical publications. Dr Green was voted American Academy of Dermatology Advocate of the year in 2018 and the National Psoriasis Foundation Clinician of the year in 2019. Dr. Green received his MD from New York Medical College and completed his dermatology and dermatologic surgery residency – and research fellowship in new treatments for aging skin and therapies for psoriasis – at the University of California, Irvine.

“I am excited and privileged to work with Biorasi in this role,” said Dr. Green. “I look forward to adding my expertise and working with other SAB members to promote growth and innovation in clinical research.”

About Biorasi

Biorasi is a customer-focused, full-service, contract research organization (CRO) that leverages speed and agility in the execution of clinical trials to maximize speed-to-market for its sponsors – all powered by our proprietary TALOS™ project management system. Biorasi is a leader in dermatology, neurology, nephrology, oncology, and the emerging digital therapeutics market. To learn more, contact Biorasi at info@biorasi.com / (786) 388-0700.

Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe